Jaguar Health (JAGX) Gross Profit Growth (1y) (2016 - 2026)
Jaguar Health (JAGX) Gross Profit Growth (1y) (2016 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Gross Profit Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
723,416.35 Bn |
723,416.32 Bn |
- |
- |
| 2 |
Belite Bio |
57,340.00 Bn |
57,340.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
19,125.08 Bn |
19,125.08 Bn |
- |
- |
| 4 |
Legend Biotech |
3,262.00 Bn |
3,261.71 Bn |
242.10 Mn |
75.94% |
| 5 |
Akari Therapeutics |
1,789.67 Bn |
1,789.67 Bn |
- |
- |
| 6 |
Evaxion A |
1,480.39 Bn |
1,480.37 Bn |
- |
- |
| 7 |
Psyence Biomedical |
241.78 Bn |
241.78 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
113.54 Bn |
106.29 Bn |
2.59 Bn |
7.76% |
| 9 |
Abivax |
94.26 Bn |
94.26 Bn |
- |
- |
| 10 |
Jaguar Health |
1.44 Mn |
-10.19 Mn |
19.11 Mn |
1,025.01% |
| Date | Value |
|---|
| Mar 31, 2026 |
1,025.01% |
| Dec 31, 2025 |
-167.77% |
| Sep 30, 2025 |
-1.09% |
| Jun 30, 2025 |
-57.23% |
| Mar 31, 2025 |
87.11% |
| Dec 31, 2024 |
304.90% |
| Sep 30, 2024 |
-52.24% |
| Jun 30, 2024 |
-45.22% |
| Mar 31, 2024 |
149.37% |
| Dec 31, 2023 |
-68.38% |
| Sep 30, 2023 |
120.85% |
| Jun 30, 2023 |
-11.36% |
| Mar 31, 2023 |
-322.76% |
| Dec 31, 2022 |
206.24% |
| Sep 30, 2022 |
7,907.69% |
| Jun 30, 2022 |
964.91% |
| Mar 31, 2022 |
51.56% |
| Dec 31, 2021 |
-84.42% |
| Sep 30, 2021 |
-98.94% |
| Jun 30, 2021 |
71.98% |
